BRISBANE, Calif. –(BUSINESS WIRE)–Dec. 6, 2019– Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the Company plans to host an R&D Day on December 17, 2019 at 8am Eastern Time in New York City . Sangamo executives and scientists will provide updates